Security key
86627R102
- Security type / class
- Equity / Stock
- Total 13F shares
- 2,320
- Total 13F value
- $44,431
- Share change
- -9,098
- SEC-reported price per share
- $19.29
- Number of holders
- 10
- Value change
- -$161,205
- Number of buys
- 10
- Number of sells
- 2
Report period
Q1 2025
Institutions
10
Top holders
10
SMMT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Summit Therapeutics Inc. SEC filings
Summit Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86627R102
Recent filing periods:
Ownership snapshot
Top reported holders of SMMT - SUMMIT THERAPEUTICS INC COM - Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
0/15
Latest evidence
31 Dec 2024
13F
Highest disclosed value: $435,861,716
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BAKER BROS. ADVISORS LP has the largest disclosed position value at $435.86M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Disclosed position value
Top 5
BAKER BROS. ADVISORS LP
$435.86M
VANGUARD GROUP INC
$208.26M
BlackRock, Inc.
$150.46M
PRICE T ROWE ASSOCIATES INC /MD/
$117M
STATE STREET CORP
$99.98M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$435,861,716
24,424,865 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$208,261,429
11,670,576 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$150,460,546
8,431,524 shares
|
— | 31 Dec 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
denominator unverified
|
$116,995,000
6,557,927 shares
|
— | 31 Dec 2024 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$99,983,929
5,602,910 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$57,133,017
3,200,847 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
2,320
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
10
Q1 2025 holders
10
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend